risk reducing mastectomy

4 trials

Sponsors

Keio University School of medicine, Aichi Cancer Center Hospital, Aichi Cancer Center Hospital, Nagoya, Japan, Mie University Hospital

Conditions

Hereditary Breast and Ovarian CancerHereditary breast and ovarian cancerhereditary breast and ovarian cancer

Phase 2

Feasibility study of risk reducing mastectomy for women with BRCA1/2 mutations.

RecruitingJPRN-UMIN000029303

Aichi Cancer Center Hospital, Nagoya, JapanHereditary Breast and Ovarian Cancer

Start: 2017-08-22Target: 10Updated: 2026-06-29

Unknown Phase

A study on safety of risk reducing mastectomy(RRM)

Active, not recruitingJPRN-UMIN000021531

Aichi Cancer Center HospitalHereditary breast and ovarian cancer

Start: 2014-04-24Target: 10Updated: 2026-06-29

Study on risku reducing mastectomy for NRCA1/2 mutation carriers

Active, not recruitingJPRN-UMIN000021254

Keio University School of medicinehereditary breast and ovarian cancer

Start: 2016-04-01Target: 100Updated: 2026-06-29

Feasibility study of risk reducing mastectomy (RRM) for BRCA1/2 mutation carriers

Active, not recruitingJPRN-UMIN000038061

Mie University HospitalHereditary breast and ovarian cancer

Start: 2019-10-01Target: 25Updated: 2026-06-29